Evidence map›Paper›PMID 37607335›Full record

ArticleSchizophrenia bulletin2024

Altered Temporal Dynamics of Resting-State Functional Magnetic Resonance Imaging in Adolescent-Onset First-Episode Psychosis.

Mireia Masias Bruns, Juan Pablo Ramirez-Mahaluf, Isabel Valli, María Ortuño, Daniel Ilzarbe, Elena de la Serna, Olga Puig Navarro, Nicolas A Crossley, Miguel Ángel González Ballester, Inmaculada Baeza and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Schizophrenia bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Mireia Masias BrunsBCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0002-0810-4336
Juan Pablo Ramirez-MahalufBCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.
Isabel ValliClinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0003-3052-7383
María OrtuñoClinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Daniel IlzarbeClinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Elena de la SernaDepartment of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Olga Puig NavarroDepartment of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain.
Nicolas A CrossleyDepartment of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0002-3060-656X
Miguel Ángel González BallesterBCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.
Inmaculada BaezaClinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Gemma PiellaBCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain.
Josefina Castro-FornielesClinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Gisela SugranyesClinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain.ORCID 0000-0002-2545-7862
Instituto de Salud Carlos III · ESPontificia Universidad Católica de Chile · CLFundació Clínic per a la Recerca Biomèdica · ESUniversitat Pompeu Fabra · ESInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

European Commission PI18/0242/PI21/0391Fundació Clínic Recerca Biomèdica and Brain and Behavior Research Foundation 26731IDIBAPS IBPS15-EE-3688Spanish Ministry of Health PI18/00976
6 · The paper itself

Abstract

backgroundDynamic functional connectivity (dFC) alterations have been reported in patients with adult-onset and chronic psychosis. We sought to examine whether such abnormalities were also observed in patients with first episode, adolescent-onset psychosis (AOP), in order to rule out potential effects of chronicity and protracted antipsychotic treatment exposure. AOP has been suggested to have less diagnostic specificity compared to psychosis with onset in adulthood and occurs during a period of neurodevelopmental changes in brain functional connections. STUDY

designSeventy-nine patients with first episode, AOP (36 patients with schizophrenia-spectrum disorder, SSD; and 43 with affective psychotic disorder, AF) and 54 healthy controls (HC), aged 10 to 17 years were included. Participants underwent clinical and cognitive assessments and resting-state functional magnetic resonance imaging. Graph-based measures were used to analyze temporal trajectories of dFC, which were compared between patients with SSD, AF, and HC. Within patients, we also tested associations between dFC parameters and clinical variables. STUDY

resultsPatients with SSD temporally visited the different connectivity states in a less efficient way (reduced global efficiency), visiting fewer nodes (larger temporal modularity, and increased immobility), with a reduction in the metabolic expenditure (cost and leap size), relative to AF and HC (effect sizes: Cohen's D, ranging 0.54 to.91). In youth with AF, these parameters did not differ compared to HC. Connectivity measures were not associated with clinical severity, intelligence, cannabis use, or dose of antipsychotic medication.

conclusionsdFC measures hold potential towards the development of brain-based biomarkers characterizing adolescent-onset SSD.

Indexed as

Antipsychotic AgentsPsychotic DisordersSchizophreniaAdolescentAdultBrainBrain MappingHumansMagnetic Resonance ImagingAntipsychotic AgentsAdolescent onset-psychosisdynamic functional connectivitygraph analysisresting-state fMRItemporal connectivity patterns

Identifiers

PMID37607335
PMCPMC10919773
OpenAlexW4386054568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.